Toggle Nav
Close
  • Menu
  • Setting

Bay 11-7821 (BAY 11-7082)

Catalog No.
A4210
IKK/NF-κB/TNFα inhibitor
Grouped product items
SizePriceStock Qty
10mg
$60.00
In stock
25mg
$120.00
In stock
50mg
$190.00
In stock
100mg
$300.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Bay 11-7821 (also known as BAY 11-7082; CAS 19542-67-7) is a selective inhibitor of IκB kinase (IKK), exhibiting an IC50 of 10 μM. It suppresses TNFα-mediated phosphorylation of IκB-α, thereby blocking NF-κB activation and subsequent expression of adhesion molecules including E-selectin, VCAM-1, and ICAM-1. Independent of NF-κB inhibition, Bay 11-7821 can induce cell death in B-cell lymphoma and leukemic T cells, and suppresses the NALP3 inflammasome activation in macrophages. Thus, it serves as an important tool for studies on inflammatory signaling pathways and apoptosis regulation.

Product Citation

Chemical Properties

StorageStore at -20°C
M.Wt207.25
Cas No.19542-67-7
FormulaC10H9NO2S
Solubilityinsoluble in H2O; ≥64 mg/mL in DMSO; ≥10.64 mg/mL in EtOH with gentle warming and ultrasonic
Chemical Name(E)-3-(4-methylphenyl)sulfonylprop-2-enenitrile
SDFDownload SDF
Canonical SMILESCC1=CC=C(C=C1)S(=O)(=O)C=CC#N
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Protocol

Cell experiment:[1]

Cell lines

Non-small cell lung cancer cell line NCI-H1703

Reaction Conditions

0 ~ 8 μM Bay 11-7821 for 12 h incubation

Applications

Bay 11-7821 (< 8 μM) was able to effectively inhibit both basal and TNFα stimulated NF-κB luciferase activity in a dose dependent manner. Bay 11-7821 (8 μM) strongly inhibited the rate of proliferation in NCI-H1703 cells.

Animal experiment:[2]

Animal models

Mice xenografted with human gastric cancer HGC27 cells

Dosage form

2.5 or 5 mg/kg

Twice-weekly intratumoral injection of Bay 11-7821, for 21 days

Applications

Treatment of Bay 11-7821 significantly suppressed tumor growth in a dose-dependent manner. Furthermore, Bay 11-7821 dose-dependently induced cellular apoptosis and inhibited proliferation in tumor xenografts.

Note

The technical data provided above is for reference only.

References:

1. Gastonguay A, Berg T, Hauser AD, et al. The role of Rac1 in the regulation of NF-κB activity, cell proliferation, and cell migration in non-small cell lung carcinoma. Cancer Biology & Therapy, 2012, 13(8): 647-656.

2. Chen L, Ruan Y, Wang X, et al. BAY 11-7082, a nuclear factor-κB inhibitor, induces apoptosis and S phase arrest in gastric cancer cells. Journal of Gastroenterology, 2014, 49(5): 864-874.

Biological Activity

Description Bay 11-7821 is an inhibitor of E2 ubiquitin (Ub) conjugating enzyme and NF-κB.
Targets E2 ubiquitin conjugating enzyme NF-κB        
IC50   10 μM        

Quality Control

Chemical structure

Bay 11-7821

Related Biological Data

Bay 11-7821

Related Biological Data

Bay 11-7821

Related Biological Data

Bay 11-7821

Related Biological Data

Bay 11-7821

Related Biological Data

Bay 11-7821

Related Biological Data

Bay 11-7821

Related Biological Data

Bay 11-7821